Cubist Sues Hospira Over Cubicin Bacteria Medicine Patent

Cubist Pharmaceuticals Inc., a maker of antibiotic medicines, sued Hospira Inc. for patent infringement over plans to market a generic version of Cubicin, a drug used to combat the MRSA flesh-eating bacterium.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.